| Gary D Call, DO | |
|
98 Poplar St, Blackfoot, ID 83221-1758 | |
| (208) 785-4100 | |
| Not Available |
| Full Name | Gary D Call |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology - Pain Medicine |
| Location | 98 Poplar St, Blackfoot, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275746646 | NPI | - | NPPES |
| HB403 | Other | ID | BLUE CROSS |
| 000010160248 | Other | ID | REGENCE BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 0-66 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gary D Call, DO 98 Poplar St, Blackfoot, ID 83221-1758 Ph: (208) 785-4100 | Gary D Call, DO 98 Poplar St, Blackfoot, ID 83221-1758 Ph: (208) 785-4100 |
News Archive
The World Health Organization cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security.
A recent study published in Acta Obstetricia et Gynecologica Scandinavica found that sons born to mothers who fell within the overweight range were more likely to be diagnosed with infertility during adulthood than sons of mothers with normal-range weight.
The U.S. Food and Drug Administration today took major steps to prevent foodborne illness by finalizing rules implementing the bipartisan Food Safety Modernization Act that, for the first time, establish enforceable safety standards for produce farms and make importers accountable for verifying that imported food meets U.S. safety standards.
Pfizer Inc today announced that the U.S. Federal Trade Commission terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to Pfizer's pending acquisition of Wyeth. In addition, Pfizer has received approval from the Canadian Competition Bureau for the pending acquisition.
Ipsen today announced the initiation of an international, multi-center, controlled, randomized Phase II clinical trial to evaluate the safety and efficacy of BN83495, its investigational first-in-class steroid sulfatase (STS) inhibitor, in advanced endometrial cancer.
› Verified 4 days ago
Ryan Grant Finn, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 98 Poplar St, Blackfoot, ID 83221 Phone: 208-239-5802 Fax: 208-232-0369 |